A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

Background: Delayed gastric emptying may impair l‐dopa absorption, contributing to motor fluctuations. We evaluated the effect of camicinal (GSK962040), a gastroprokinetic, on the absorption of l‐dopa and symptoms of PD. Methods: Phase II, double‐blind, placebo‐controlled trial. Participants were ra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mov Disord
Autors principals: Marrinan, Sarah L., Otiker, Tal, Vasist, Lakshmi S., Gibson, Rachel A., Sarai, Bhopinder K., Barton, Matthew E., Richards, Duncan B., Hellström, Per M., Nyholm, Dag, Dukes, George E., Burn, David J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838770/
https://ncbi.nlm.nih.gov/pubmed/29278279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27259
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars